A 57-Week, Multicenter, Active-treatment, Open-label Extension Trial of CVL-865 as Adjunctive Therapy in Adults with Drug-Resistant Focal Onset Seizures.

Project: Research

Project Details

StatusActive
Effective start/end date18/12/2031/12/24

Keywords

  • Epilepsy
  • Seizures
  • Clinical trial